William D Clark insider trades
Open-market stock purchases and sales by William D Clark, Director at iBio, Inc, from SEC Form 4 filings since Jan 1, 2010.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -71%.
Companies traded
- IBIO iBio, Inc: 1 buy, last Oct 14, 2026
- ALDX Aldeyra Therapeutics, Inc: other filings, last Jun 9, 2026
- GNCA Genocea Biosciences, Inc: 4 buys, 4 sales, last Jun 2, 2022
- ASNS Arsanis, Inc: other filings, last Jun 5, 2018
- PROJ Deltek, Inc: 3 sales, last Feb 24, 2010
- VNDA Vanda Pharmaceuticals Inc: 1 sale, last Feb 19, 2010